Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Douglas S. Ingram currently holds 46,215 shares of Sarepta Therapeutics, Inc. (SRPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Douglas S. Ingram has been a net seller of SRPT stock. They have purchased $14.6M and sold $33.4M worth of shares.
Douglas S. Ingram's most recent insider trade was on Dec 16, 2025, when they sold 7,819 shares at $0.00 per share.
Douglas S. Ingram serves as Executive at Sarepta Therapeutics, Inc. (SRPT). They have executed 83 insider transactions totaling $48.0M over their tenure at the company.
Douglas S. Ingram holds the position of Executive at Sarepta Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Douglas S. Ingram has shown a selling trading pattern, with $14.6M in total purchases and $33.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Douglas S. Ingram was on Feb 14, 2014, when they sold $10.4M worth of AGN shares. This transaction involved 84,000 shares at $124.40 per share.
Douglas S. Ingram currently owns 46,215 shares of Sarepta Therapeutics, Inc. (SRPT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Douglas S. Ingram's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Douglas S. Ingram has 83 Form 4 filings on record as an insider at Sarepta Therapeutics, Inc..
Set alerts for Douglas S. Ingram and 40,000+ other insiders.